These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252 [TBL] [Abstract][Full Text] [Related]
66. Investigation of Carbapenem resistance mechanisms in Klebsiella pneumoniae by using phenotypic tests and a molecular assay. Ciftci E; Sesli Cetin E; Us E; Haydar Kutlu H; Cicioglu Arıdogan B J Infect Dev Ctries; 2019 Nov; 13(11):992-1000. PubMed ID: 32087071 [TBL] [Abstract][Full Text] [Related]
67. Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal. Thapa S; Adhikari N; Shah AK; Lamichhane I; Dhungel B; Shrestha UT; Adhikari B; Banjara MR; Ghimire P; Rijal KR Chemotherapy; 2021; 66(5-6):199-209. PubMed ID: 34515078 [TBL] [Abstract][Full Text] [Related]
68. A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring Niu S; Chavda KD; Wei J; Zou C; Marshall SH; Dhawan P; Wang D; Bonomo RA; Kreiswirth BN; Chen L mSphere; 2020 Aug; 5(4):. PubMed ID: 32848008 [TBL] [Abstract][Full Text] [Related]
69. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains. Morici P; Florio W; Rizzato C; Ghelardi E; Tavanti A; Rossolini GM; Lupetti A Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1739-1748. PubMed ID: 28470337 [TBL] [Abstract][Full Text] [Related]
70. Clonal Dissemination of KPC-2, VIM-1, OXA-48-Producing Ochońska D; Klamińska-Cebula H; Dobrut A; Bulanda M; Brzychczy-Włoch M Pol J Microbiol; 2021 Mar; 70(1):107-116. PubMed ID: 33815532 [TBL] [Abstract][Full Text] [Related]
71. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M; BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727 [TBL] [Abstract][Full Text] [Related]
72. Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance. Adler A; Ben-Dalak M; Chmelnitsky I; Carmeli Y Antimicrob Agents Chemother; 2015 Aug; 59(8):5014-7. PubMed ID: 25987630 [TBL] [Abstract][Full Text] [Related]
73. Higher Rate of Extreme Drug-resistant Klebsiella pneumoniae Infections among Cardiac Patients. Paudel S; Shah PK; Adhikari P; Singh K C S; Thapa Shrestha U J Nepal Health Res Counc; 2022 Mar; 19(4):661-668. PubMed ID: 35615819 [TBL] [Abstract][Full Text] [Related]
74. Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital. Battikh H; Harchay C; Dekhili A; Khazar K; Kechrid F; Zribi M; Masmoudi A; Fendri C Microb Drug Resist; 2017 Jun; 23(4):468-472. PubMed ID: 27802107 [TBL] [Abstract][Full Text] [Related]
75. Evaluation of Modified Hodge Test as a Non-molecular Assay for Accurate Detection of KPC-producing Ghasemnejad A; Doudi M; Amirmozafari N Pol J Microbiol; 2018; 67(3):291-295. PubMed ID: 30451445 [TBL] [Abstract][Full Text] [Related]
76. Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis. Tattevin P; Dinh A; Ghout I; Mouton W; Verdier MC; Laurent F; Lemaitre F; Gatin L; Saleh-Mghir A; Crémieux AC Int J Antimicrob Agents; 2020 Nov; 56(5):106152. PubMed ID: 32898684 [TBL] [Abstract][Full Text] [Related]
77. Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. Ceccarelli G; Falcone M; Giordano A; Mezzatesta ML; Caio C; Stefani S; Venditti M Antimicrob Agents Chemother; 2013 Jun; 57(6):2900-1. PubMed ID: 23571536 [No Abstract] [Full Text] [Related]
78. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). Zhang Y; Kashikar A; Bush K J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224 [TBL] [Abstract][Full Text] [Related]
79. Phenotypic screening of carbapenemases and associated β-lactamases in carbapenem-resistant Enterobacteriaceae. Birgy A; Bidet P; Genel N; Doit C; Decré D; Arlet G; Bingen E J Clin Microbiol; 2012 Apr; 50(4):1295-302. PubMed ID: 22259214 [TBL] [Abstract][Full Text] [Related]
80. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]